Drug-drug Interaction (DDI) Study of GSK3640254 With Darunavir/Ritonavir (DRV/RTV) and Etravirine (ETR)
Clinical trial NCT04630002 · COMPLETED
Trial details
- NCT number
- NCT04630002
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-28
- Primary completion
- 2021-10-02
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.